Renu Meena

Renu Meena

Medical Content Writer

About Renu Meena

Renu Meena is a Medical Content Writer with a strong pharmacy-practice background and a B.Pharm from Rajasthan University of Health Sciences (RUHS), Jaipur. With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Qualification
Bachelor of Pharmacy (B.Pharm)
Experience
4+ years
Specialization
  • Medical & Pharmaceutical Content Writing (products + blogs + patient education)
  • Disease Education and disease management guide
  • Medication Use Content (how to use, safety, precautions, adherence support)
  • Drug Safety / Pharmacovigilance content
  • Regulatory-aligned writing, including familiarity with: ICH guidelines, GVP modules, ICD-10 and ICD-11, CIOMS working groups, Regulatory reporting obligations, Patient safety analysis activities
  • Content types: evidence-based articles, educational materials, compliance-friendly health content
Experience
  • Started career as a Pharmacist, building hands-on expertise in:

    • Medication management

    • Patient counselling

    • Practical pharmaceutical care workflows

  • Transitioned into Medical Writing / Disease Content / Medical Affairs, contributing to:

    • Product/medicine information content

    • Disease education and management guides

    • Drug safety and compliance-focused health content

  • Known for detail orientation, research strength, and staying updated with pharmacology and healthcare advancements

Articles by Renu Meena

Symptoms of Breast Cancer

Breast cancer is a significant health concern, being the second most diagnosed cancer among women worldwide. It can also occur in men.It affects approximately 1 in 8 women in the U.S., underscoring the importance of awareness and early detection.The disease develops when breast tissue cells grow uncontrollably. This abnormal growth...

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer

On October 10, 2024, the Food and Drug Administration (FDA) approved Inavolisib, in combination with Palbociclib and Fulvestrant, for adults with advanced breast cancer that meets specific criteria. This approval is essential for patients who have:Endocrine-resistant breast cancerPIK3CA-mutated tumorsHormone receptor (HR)-positive statusHER2-negative statusLocally advanced or metastatic disease, as identified by an FDA-approved...

Premature Ejaculation Unveiled: Symptoms, Causes, and Treatments

Premature ejaculation (PE) is the most common sexual problem in men, affecting about 20-30%  men worldwide. It can impact relationships, causing stress for the man and his partner, but understanding its symptoms, causes, dosage, and treatments may help a person suffering from PE.You may feel self-conscious if you have experienced Premature...